MwanzoVCEL • NASDAQ
add
Vericel Corp
Bei iliyotangulia
$ 59.53
Bei za siku
$ 57.58 - $ 60.13
Bei za mwaka
$ 36.35 - $ 60.16
Thamani ya kampuni katika soko
2.94B USD
Wastani wa hisa zilizouzwa
elfu 349.90
Uwiano wa bei na mapato
769.13
Mgao wa faida
-
Ubadilishanaji wa msingi
NASDAQ
Habari za soko
Fedha
Taarifa ya Mapato
Mapato
Mapato halisi
(USD) | Sep 2024info | Mabadiliko Tangu Mwaka Uliopita |
---|---|---|
Mapato | 57.90M | 27.04% |
Matumizi ya uendeshaji wa biashara | 44.12M | 23.70% |
Mapato halisi | elfu -901.00 | 75.38% |
Kiwango cha faida halisi | -1.56 | 80.57% |
Mapato kwa kila hisa | 0.02 | 136.80% |
EBITDA | -1.14M | 70.82% |
Asilimia ya kodi ya mapato | — | — |
Taarifa ya Hali ya Kifedha
Jumla ya mali
Jumla ya dhima
(USD) | Sep 2024info | Mabadiliko Tangu Mwaka Uliopita |
---|---|---|
Uwekezaji wa pesa taslimu na vipindi vifupi | 101.73M | -3.43% |
Jumla ya mali | 390.40M | 22.72% |
Jumla ya dhima | 132.93M | 16.87% |
Jumla ya hisa | 257.47M | — |
hisa zilizosalia | 49.36M | — |
Uwiano wa bei na thamani | 11.38 | — |
Faida inayotokana na mali | -1.61% | — |
Faida inayotokana mtaji | -1.78% | — |
Mtiririko wa pesa
Mabadiliko halisi ya pesa taslimu
(USD) | Sep 2024info | Mabadiliko Tangu Mwaka Uliopita |
---|---|---|
Mapato halisi | elfu -901.00 | 75.38% |
Pesa kutokana na shughuli | 10.18M | 42.06% |
Pesa kutokana na uwekezaji | -21.21M | -564.56% |
Pesa kutokana na ufadhili | 5.52M | 447.47% |
Mabadiliko halisi ya pesa taslimu | -5.50M | -143.19% |
Mtiririko huru wa pesa | -5.60M | -200.17% |
Kuhusu
Vericel Corporation is a publicly traded American biopharmaceutical company which was known prior to October 2014 as Aastrom Bio. Aastrom Bio was formed in 1989 in Ann Arbor, Michigan.
In the spring of 2014, Aastrom Bio acquired Sanofi's cell therapy and regenerative medicine business which Sanofi had acquired when purchasing Genzyme in 2011. This transformed Aastrom in several ways: it increased the employee count by 8-fold and provided a revenue stream and products to market, which it had not had before.
In October 2014, the company changed its name from Aastrom Bio to Vericel and relocated its headquarters from Ann Arbor, Michigan to Cambridge, Massachusetts. Wikipedia
Afisa Mkuu Mtendaji (CEO)
Ilianzishwa
1989
Makao Makuu
Tovuti
Wafanyakazi
314